@article{0b8b87bfe7084ee98e3ee287565b1cb3,
title = "Next-generation medicine: Combining BCR-ABL and hedgehog-targeted therapies",
abstract = "Disease relapse remains a major cause of death in patients with BCR-ABL-positive leukemia despite advances in treatment with kinase inhibitors. Significant efforts are underway to target pathways that maintain leukemia stem cells. Targeting these pathways holds promise for definitive leukemia eradication or improvement of the effectiveness of currently available therapies.",
author = "Dao, \{Kim Hien T.\} and Tyner, \{Jeffrey W.\}",
year = "2013",
month = mar,
day = "15",
doi = "10.1158/1078-0432.CCR-12-3934",
language = "English (US)",
volume = "19",
pages = "1309--1311",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "6",
}